Significance of omega-3 polyunsaturated fatty acid administration in the therapeutic approach of depression in hemodialysis patients
Autor: | Sofia Kalatzi, Ioannis Giannikouris, Antonios Arvanitis, Ekaterini Georgopoulou, Agelos Zervos, Ioannis Choustoulakis, Christina Bornivelli, Polichronis Alivanis |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2008 |
Předmět: |
chemistry.chemical_classification
medicine.medical_specialty business.industry lcsh:RC435-571 medicine.medical_treatment Sequela medicine.disease Surgery End stage renal disease Therapeutic approach Psychiatry and Mental health Mood chemistry Internal medicine lcsh:Psychiatry medicine Hemodialysis Psychopharmacology Psychiatry business Depression (differential diagnoses) Polyunsaturated fatty acid |
Zdroj: | Annals of General Psychiatry, Vol 7, Iss Suppl 1, p S255 (2008) |
Popis: | According to various reports and clinical studies mentaldisorders represent a frequent sequela of chronic diseases.In end stage renal disease, in particular, mood disordersand more specifically major depression is met with a fre-quency of 20-30% and is the most widely acknowledgedabnormality [1]. As a consequence, overall quality of lifeas well as treatment compliance is severely impaired [2].Omega-3 (Ω3) polyunsaturated fatty acids (PUFAs) havebeen shown to reduce the risk and to treat mental disor-ders including depression [3]. However, evidence to date,remains obscure and recommendations must be givenwith caution [4]. The aim of the present study was to eval-uate the significance of Ω3 administration in the treat-ment of depressive maintenance hemodialysis (HD)patients. |
Databáze: | OpenAIRE |
Externí odkaz: |